Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Intraductal papillary mucinous neoplasms of the pancreas—a surgical disease

Abstract

Cystic pancreatic neoplasms are increasingly recognized, with intraductal papillary mucinous neoplasms of the pancreas (IPMNs) being the most frequently observed type. IPMNs are characterized by mucin production and epithelial growth within the pancreatic ducts, and are generally differentiated according to location: main pancreatic duct, its major side branches, or both (mixed type). IPMNs vary from benign to malignant and are considered precursor lesions of pancreatic adenocarcinoma. However, the exact time to neoplastic transformation and whether all IPMNs progress to malignant tumors is unclear. Surgical resection is warranted for all main-duct and mixed-type IPMNs (they harbor a high risk of malignancy of 70%). By contrast, branch-duct IPMNs progress to cancer in only 30% of cases. Thus, according to current guidelines (Sendai criteria), asymptomatic side-branch IPMNs <3 cm in size without suspicious radiological features (such as size progression) can be treated conservatively. Lately, even this approach has become controversial, owing to a number of Sendai-negative IPMNs showing malignant transformation. Although most IPMNs should be resected by standard oncological procedures (including lymphadenectomy), small Sendai-negative IPMNs can be treated with limited resections. This Review summarizes current knowledge of the treatment of IPMNs, with a particular focus on surgical approaches to this disease.

Key Points

  • According to modern thin-slice abdominal imaging or endoscopic ultrasonography, intraductal papillary mucinous neoplasms of the pancreas (IPMNs) can be distinguished into three types: main duct, branch duct, or mixed

  • Currently, all three IPMN types are considered precursors to invasive adenocarcinoma of the pancreas with varying risks of malignant transformation

  • Owing to their high rates of malignancy, main-duct IPMNs and mixed-type IPMNs should be oncologically resected whenever the patient is an adequate candidate for surgery

  • According to current treatment guidelines (Sendai criteria), asymptomatic branch-duct IPMNs <3 cm in size without suspicious radiological features can be treated conservatively

  • Surgery for small branch-duct IPMNs remains controversial; malignant transformation even in small branch-duct IPMNs without suspicious features is increasingly reported, in which case, the Sendai criteria should be re-evaluated

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Surgical treatment of main-duct IPMN.
Figure 2: Surgical treatment of a branch-duct IPMN.

Similar content being viewed by others

References

  1. Hivet, M., Maisel, A., Horiot, A. & Conte, J. Diffuse villous carcinoma of Wirsung's duct. Total pancreatectomy [French]. Med. Chir. Dig. 4, 159–623 (1975).

    CAS  PubMed  Google Scholar 

  2. Kloppel, G. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas. Hepatogastroenterology 45, 1981–1985 (1998).

    CAS  PubMed  Google Scholar 

  3. Haban, G. Papillomatosis and carcinoma of the ductal system of the pancreas. Virchows Arch. A Pathol. Anat. 297, 207–220 (1936).

    Article  Google Scholar 

  4. Kloppel, G., Kosmahl, M. & Luttges, J. Intraductal neoplasms of the pancreas: cystic and common [German]. Pathologe 26, 31–36 (2005).

    Article  CAS  PubMed  Google Scholar 

  5. Ohashi, K. et al. Four cases of mucous secreting pancreatic cancer. Prog. Dig. Endosc. 20, 348–351 (1982).

    Google Scholar 

  6. Agostini, S. et al. Mucinous pancreatic duct ectasia in the body of the pancreas. Radiology 170, 815–816 (1989).

    Article  CAS  PubMed  Google Scholar 

  7. Payan, M. J. et al. Villous adenoma of the main pancreatic duct: a potentially malignant tumor? Am. J. Gastroenterol. 85, 459–463 (1990).

    CAS  PubMed  Google Scholar 

  8. Sessa, F. et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 425, 357–367 (1994).

    Article  CAS  PubMed  Google Scholar 

  9. Morohoshi, T., Kanda, M., Asanuma, K. & Kloppel, G. Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients. Cancer 64, 1329–1335 (1989).

    Article  CAS  PubMed  Google Scholar 

  10. Tanaka, M. et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6, 17–32 (2006).

    Article  PubMed  Google Scholar 

  11. Kloppel, G., Solcia, E., Longnecker, D. S. & Sobin, L. H. in World Health Organization International Histological Classification of Tumours 2nd ed. 15–21 (Springer, Berlin, 1996).

    Google Scholar 

  12. Bosman, F. T., Carneiro, F., Hruban, R. H. & Theise, N. D. (eds) WHO Classification of Tumours of the Digestive System. (WHO Press, Switzerland, 2010).

    Google Scholar 

  13. Volkan Adsay, N. Cystic lesions of the pancreas. Mod. Pathol. 20 (Suppl. 1), S71–S93 (2007).

    Article  PubMed  Google Scholar 

  14. Hruben, R. H., Pitman, M. B. & Klimstra, D. S. in Tumors of the Pancreas 4th edn 75–110, (American Registry of Pathlogy, Washington, 2007).

    Google Scholar 

  15. Kimura, W., Nagai, H., Kuroda, A., Muto, T. & Esaki, Y. Analysis of small cystic lesions of the pancreas. Int. J. Pancreatol. 18, 197–206 (1995).

    CAS  PubMed  Google Scholar 

  16. Kosmahl, M. et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch. 445, 168–178 (2004).

    Article  CAS  PubMed  Google Scholar 

  17. Conlon, K. C. Intraductal papillary mucinous tumors of the pancreas. J. Clin. Oncol. 23, 4518–4523 (2005).

    Article  PubMed  Google Scholar 

  18. Fernandez-del Castillo, C. et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch. Surg. 138, 427–433 (2003).

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sarr, M. G. et al. Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions. J. Gastrointest. Surg. 7, 417–428 (2003).

    Article  PubMed  Google Scholar 

  20. Sohn, T. A. et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann. Surg. 239, 788–797 (2004).

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wada, K., Kozarek, R. A. & Traverso, L. W. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am. J. Surg. 189, 632–636 (2005).

    Article  PubMed  Google Scholar 

  22. Spinelli, K. S. et al. Cystic pancreatic neoplasms: observe or operate. Ann. Surg. 239, 651–657 (2004).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Chiu, S. S. et al. Intraductal papillary mucinous tumour of the pancreas: differentiation of malignancy and benignancy by CT. Clin. Radiol. 61, 776–783 (2006).

    Article  PubMed  Google Scholar 

  24. Sahani, D. V. et al. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP. Radiology 238, 560–569 (2006).

    Article  PubMed  Google Scholar 

  25. Irie, H. et al. MR cholangiopancreatographic differentiation of benign and malignant intraductal mucin-producing tumors of the pancreas. AJR Am. J. Roentgenol. 174, 1403–1408 (2000).

    Article  CAS  PubMed  Google Scholar 

  26. Kalra, M. K., Maher, M. M., Sahani, D. V., Digmurthy, S. & Saini, S. Current status of imaging in pancreatic diseases. J. Comput. Assist. Tomogr. 26, 661–675 (2002).

    Article  PubMed  Google Scholar 

  27. Waters, J. A. et al. CT vs MRCP: optimal classification of IPMN type and extent. J. Gastrointest. Surg. 12, 101–109 (2008).

    Article  PubMed  Google Scholar 

  28. Tollefson, M. K. et al. Intraductal papillary mucinous neoplasm: did it exist prior to 1980? Pancreas 26, e55–e58 (2003).

    Article  PubMed  Google Scholar 

  29. Laffan, T. A. et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am. J. Roentgenol. 191, 802–807 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  30. de Jong, K. et al. High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin. Gastroenterol. Hepatol. 8, 806–811 (2010).

    Article  PubMed  Google Scholar 

  31. Salvia, R. et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann. Surg. 239, 678–685 (2004).

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kamisawa, T. et al. Long-term follow-up of intraductal papillary adenoma of the pancreas. J. Gastroenterol. 37, 868–873 (2002).

    Article  PubMed  Google Scholar 

  33. D'Angelica, M., Brennan, M. F., Suriawinata, A. A., Klimstra, D. & Conlon, K. C. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann. Surg. 239, 400–408 (2004).

    Article  PubMed  PubMed Central  Google Scholar 

  34. Rodriguez, J. R. et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 133, 72–79 (2007).

    Article  PubMed  Google Scholar 

  35. Schmidt, C. M. et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann. Surg. 246, 644–651 (2007).

    Article  PubMed  Google Scholar 

  36. Ingkakul, T. et al. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann. Surg. 251, 70–75 (2010).

    Article  PubMed  Google Scholar 

  37. Sato, N. et al. STK11/LKB1 Peutz–Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am. J. Pathol. 159, 2017–2022 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Chetty, R. et al. Intraductal papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis. J. Clin. Pathol. 58, 97–101 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Yamaguchi, K., Yokohata, K., Noshiro, H., Chijiiwa, K. & Tanaka, M. Mucinous cystic neoplasm of the pancreas or intraductal papillary-mucinous tumour of the pancreas. Eur. J. Surg. 166, 141–148 (2000).

    Article  CAS  PubMed  Google Scholar 

  40. Eguchi, H. et al. Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development. Surgery 139, 749–754 (2006).

    Article  PubMed  Google Scholar 

  41. Reid-Lombardo, K. M., Mathis, K. L., Wood, C. M., Harmsen, W. S. & Sarr, M. G. Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas: implications for management. Ann. Surg. 251, 64–69 (2010).

    Article  PubMed  Google Scholar 

  42. Hruban, R. H. et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am. J. Surg. Pathol. 28, 977–987 (2004).

    Article  PubMed  Google Scholar 

  43. Salvia, R. et al. Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas. World J. Gastrointest. Surg. 2, 342–346 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  44. Pelaez-Luna, M. et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am. J. Gastroenterol. 102, 1759–1764 (2007).

    Article  PubMed  Google Scholar 

  45. Basturk, O., Coban, I. & Adsay, N. V. Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications. Arch. Pathol. Lab. Med. 133, 423–438 (2009).

    PubMed  Google Scholar 

  46. Tanno, S. et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas 39, 36–40 (2010).

    Article  PubMed  Google Scholar 

  47. Hruban, R. H. & Adsay, N. V. Molecular classification of neoplasms of the pancreas. Hum. Pathol. 40, 612–623 (2009).

    Article  CAS  PubMed  Google Scholar 

  48. Fritz, S. et al. Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma. Ann. Surg. 249, 440–447 (2009).

    Article  PubMed  Google Scholar 

  49. Z'Graggen, K. et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann. Surg. 226, 491–498 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Fernandez-del Castillo, C. & Adsay, N. V. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 139, 708–713 (2010).

    Article  PubMed  Google Scholar 

  51. Adsay, N. V. et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas. Am. J. Surg. Pathol. 28, 839–848 (2004).

    Article  PubMed  Google Scholar 

  52. Luttges, J., Feyerabend, B., Buchelt, T., Pacena, M. & Kloppel, G. The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am. J. Surg. Pathol. 26, 466–471 (2002).

    Article  CAS  PubMed  Google Scholar 

  53. Nakamura, A. et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J. Pathol. 197, 201–210 (2002).

    Article  PubMed  Google Scholar 

  54. Furukawa, T. et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 447, 794–799 (2005).

    Article  PubMed  Google Scholar 

  55. Mino-Kenudson, M. et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 60, 1712–1720 (2011).

    Article  PubMed  Google Scholar 

  56. Luttges, J., Zamboni, G., Longnecker, D. & Kloppel, G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am. J. Surg. Pathol. 25, 942–948 (2001).

    Article  CAS  PubMed  Google Scholar 

  57. Basturk, O. et al. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis. Am. J. Surg. Pathol. 34, 364–370 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  58. Salvia, R. et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 56, 1086–1090 (2007).

    Article  PubMed  Google Scholar 

  59. Warshaw, A. L., Compton, C. C., Lewandrowski, K., Cardenosa, G. & Mueller, P. R. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann. Surg. 212, 432–443 (1990).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Thompson, L. D., Becker, R. C., Przygodzki, R. M., Adair, C. F. & Heffess, C. S. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. Am. J. Surg. Pathol. 23, 1–16 (1999).

    Article  CAS  PubMed  Google Scholar 

  61. Nakagohri, T., Kenmochi, T., Kainuma, O., Tokoro, Y. & Asano, T. Intraductal papillary mucinous tumors of the pancreas. Am. J. Surg. 178, 344–347 (1999).

    Article  CAS  PubMed  Google Scholar 

  62. Falconi, M. et al. Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br. J. Surg. 88, 376–381 (2001).

    Article  CAS  PubMed  Google Scholar 

  63. Tanaka, M. et al. International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas. Pancreatology 6, 17–32 (2005).

    Article  Google Scholar 

  64. Sahani, D. V., Shah, Z. K., Catalano, O. A., Boland, G. W. & Brugge, W. R. Radiology of pancreatic adenocarcinoma: current status of imaging. J. Gastroenterol. Hepatol. 23, 23–33 (2008).

    Article  PubMed  Google Scholar 

  65. Ferrone, C. R. et al. Current trends in pancreatic cystic neoplasms. Arch. Surg. 144, 448–454 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  66. Waters, J. A. & Schmidt, C. M. Intraductal papillary mucinous neoplasm—when to resect? Adv. Surg. 42, 87–108 (2008).

    Article  PubMed  Google Scholar 

  67. Pitman, M. B. et al. Pancreatic cysts: preoperative diagnosis and clinical management. Cancer Cytopathol. 118, 1–13 (2010).

    Article  PubMed  Google Scholar 

  68. Fritz, S., Warshaw, A. L. & Thayer, S. P. Management of mucin-producing cystic neoplasms of the pancreas. Oncologist 125–136 (2009).

  69. Schnelldorfer, T. et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch. Surg. 143, 639–646 (2008).

    Article  PubMed  Google Scholar 

  70. Bendix Holme, J., Jacobsen, N. O., Rokkjaer, M. & Kruse, A. Total pancreatectomy in six patients with intraductal papillary mucinous tumour of the pancreas: the treatment of choice. HPB (Oxford) 3, 257–262 (2001).

    Article  CAS  Google Scholar 

  71. Chari, S. T. et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 123, 1500–1507 (2002).

    Article  PubMed  Google Scholar 

  72. Jang, J. Y. et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann. Surg. Oncol. 12, 124–132 (2005).

    Article  PubMed  Google Scholar 

  73. Maire, F. et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 51, 717–722 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Tang, R. S. et al. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin. Gastroenterol. Hepatol. 6, 815–819 (2008).

    Article  PubMed  Google Scholar 

  75. Wasif, N. et al. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes. Cancer 116, 3369–3377 (2010).

    Article  PubMed  Google Scholar 

  76. Poultsides, G. A. et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann. Surg. 251, 470–476 (2010).

    Article  PubMed  Google Scholar 

  77. Jang, J. Y. et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann. Surg. Oncol. 15, 199–205 (2008).

    Article  PubMed  Google Scholar 

  78. Sawai, Y. et al. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy 42, 1077–1084 (2010).

    Article  CAS  PubMed  Google Scholar 

  79. Fritz, S. et al. Small (Sendai negative) branch-duct IPMNs: not harmless. Ann. Surg. (in press).

  80. Gerke, H. et al. Endoscopic ultrasound and computer tomography are inaccurate methods of classifying cystic pancreatic lesions. Dig. Liver Dis. 38, 39–44 (2006).

    Article  CAS  PubMed  Google Scholar 

  81. Fritz, S. et al. Role of serum carbohydrate antigen 19–19 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br. J. Surg. 98, 104–110 (2011).

    Article  CAS  PubMed  Google Scholar 

  82. Crippa, S. et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin. Gastroenterol. Hepatol. 8, 213–219 (2010).

    Article  PubMed  Google Scholar 

  83. Cameron, J. L., Riall, T. S., Coleman, J. & Belcher, K. A. One thousand consecutive pancreaticoduodenectomies. Ann. Surg. 244, 10–15 (2006).

    Article  PubMed  PubMed Central  Google Scholar 

  84. Wagner, M. et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br. J. Surg. 91, 586–594 (2004).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors researched data for the article, and reviewed and edited the manuscript before submission. J. Werner and B. W. Büchler made equal contributions to discussion of content, and J. Werner and S. Fritz wrote the article.

Corresponding author

Correspondence to Markus W. Büchler.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Werner, J., Fritz, S. & Büchler, M. Intraductal papillary mucinous neoplasms of the pancreas—a surgical disease. Nat Rev Gastroenterol Hepatol 9, 253–259 (2012). https://doi.org/10.1038/nrgastro.2012.31

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2012.31

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer